Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look ...

ImmunityBio (NASDAQ:IBRX) said on Monday that the U.S. FDA has approved expanded access for its Cancer BioShield platform, ...

The analyst supported the positive rating with Ojemda’s potential, which is a prescription medicine that treats certain brain ...

Amylyx Pharmaceuticals (NASDAQ:AMLX) said on Tuesday that the U.S. FDA has granted fast track status to its antisense RNA, ...

Ascendis Pharma A/S (Nasdaq: ASND) today announced that the U.S. Food & Drug Administration (FDA) has accepted for priority review its New Drug Application (NDA) for TransCon CNP (navepegritide ...

Wrapping up Q1 earnings, we look at the numbers and key takeaways for the surgical equipment & consumables - specialty stocks ...

The U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) for ziftomenib, an investigational ...

Hyperfine HYPR recently announced FDA 510(k) clearance for its next-generation Swoop Portable MR Imaging system. The clearance covers an entirely new portable magnetic resonance imaging (MRI ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

Moderna (NASDAQ:MRNA) announced on Saturday that the U.S. Food and Drug Administration (FDA) approved its next-gen COVID-19 ...

The FDA is set to decide by June 10 ... views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New York, with ...

Taysha Gene Therapies (NASDAQ: TSHA) saw its stock surge 19% after unveiling critical updates on the design of its pivotal ...